Financhill
Back

Elanco Animal Health Quote, Financials, Valuation and Earnings

Elanco Animal Health Price Quote

$14.04
-0.15 (-1.06%)
(Updated: November 14, 2024 at 5:55 PM ET)

Elanco Animal Health Key Stats

Buy
65
Elanco Animal Health (ELAN) is a Buy

Day range:
$14.13 - $14.32
52-week range:
$10.90 - $18.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.57
P/B ratio:
1.07%

Volume:
3.5M
Avg. volume:
4.3M
1-year change:
34.5%
Market cap:
$7B
Revenue:
$4.4B
EPS:
$0.4

How Much Does Elanco Animal Health Make?

Is Elanco Animal Health Growing As A Company?

  • What Is Elanco Animal Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.04%
  • What Is Elanco Animal Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Elanco Animal Health Stock Price Performance

What Is Elanco Animal Health 52-Week High & Low?

Elanco Animal Health Price To Free Cash Flow

Is It Risky To Buy Elanco Animal Health?

Is Elanco Animal Health Cash Flow Positive?

  • What Is ELAN Cash Flow From Operations?
    Cash flow from operations (TTM) is $521M
  • What Is Elanco Animal Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.6B
  • What Is Elanco Animal Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $1.2B

Elanco Animal Health Return On Invested Capital

  • Is Management Doing A Good Job?
    ELAN return on invested capital is 1.76%
  • What Is Elanco Animal Health Return On Assets?
    ROA measures how assets are converting to revenues and is 1.47%
  • What Is ELAN Return On Equity?
    ROE is a measure of profitability and is 3.32%

Elanco Animal Health Earnings Date & Stock Price

Elanco Animal Health Competitors

  • Who Are Elanco Animal Health's Competitors?
    Below is a list of companies who compete with Elanco Animal Health or are related in some way:
    • Baxter International Inc (BAX)
    • Edwards Lifesciences Corp (EW)
    • Edgewise Therapeutics Inc (EWTX)
    • Opus Genetics Inc (IRD)
    • Syros Pharmaceuticals Inc (SYRS)

Elanco Animal Health Dividend Yield

Elanco Animal Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.03%
Revenue: -3.56% -0.41%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 18.02
Upside from Last Price: 27.02%

Major Shareholders

  • How many ELAN shares are owned by institutional investors?
    709.6M ELAN shares are owned by institutional investors
  • How many ELAN shares are owned by insiders?
    3.4M ELAN shares are owned by insiders